Showing results (311-320 of 430) with videos related to
Sort By:
Pageof 43
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 8, 2011
Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantationSee Ching Chan, Chung Mau Lo, Kenneth S H Chok, et al.ANZ Journal of Surgery|July 2, 2013
Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective studyKenneth S H Chok, Tan To Cheung, Albert C Y Chan, et al.Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 30, 2007
Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathwaysKwan Man, Kevin T Ng, Chung Mau Lo, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 10, 2012
The impact of family history of hepatocellular carcinoma on its patients' survivalWing Chiu Dai, Sheung Tat Fan, Tan To Cheung, et al.Annals of Surgery|April 9, 2011
Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experienceSheung Tat Fan, Chung Mau Lo, Ronnie T P Poon, et al.Plos One|March 3, 2012
FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cellsChang Xian Li, Yan Shao, Kevin T P Ng, et al.Hepatology International|October 22, 2011
Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasionSee Ching Chan, Sheung Tat Fan, Kenneth S H Chok, et al.Carcinogenesis|August 7, 2004
FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylationTerence K Lee, Kwan Man, Joanna W Ho, et al.Carcinogenesis|December 18, 2004
Significance of the Rac signaling pathway in HCC cell motility: implications for a new therapeutic targetTerence K Lee, Kwan Man, Joanna W Ho, et al.Journal of Clinical Gastroenterology|March 18, 2008
Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complicationsChee-Kin Hui, Nancy Leung, Wai-Hung Shek, et al.Pageof 43